MOMENTUM
Recruiting
8,000 enrolled
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Phase 1 Recruiting
97 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
DP-04
Recruiting
100 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 Recruiting
150 enrolled
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
796 enrolled
iCaRe2
Recruiting
999,999 enrolled
PTC-IMPACT
Recruiting
50 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Recruiting
320 enrolled
OvAR-Y
Recruiting
10 enrolled
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 Recruiting
126 enrolled
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 Recruiting
51 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
4D-MRI for Precision Medicine
Recruiting
100 enrolled
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase 1 Recruiting
70 enrolled
INSPIRE
Recruiting
5,350 enrolled
RespEcran
Phase NA Recruiting
100 enrolled
TEG
Recruiting
400 enrolled
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Phase NA Recruiting
1,000,000 enrolled
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Recruiting
620 enrolled
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Recruiting
12,000 enrolled
Interventional Software for Multi-immunotherapy of Solid Tumors
Phase 2/3 Recruiting
60 enrolled
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Phase 1 Recruiting
30 enrolled
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
Phase 1 Recruiting
40 enrolled
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/2 Recruiting
100 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
ONFM-SBRT
Recruiting
57 enrolled
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
Phase 4 Recruiting
1,316 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled